{"id":"W2165254737","doi":"10.1200/jco.2008.18.0612","title":"Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; University of California, Los Angeles; Genentech; American Society of Clinical Oncology; Bristol-Myers Squibb","keywords":"Medicine; Erlotinib; Temozolomide; Internal medicine; Oncology; Clinical endpoint; Radiation therapy; PTEN; Rash; Epidermal growth factor receptor; Cancer; EGFR inhibitors; Clinical trial; PI3K/AKT/mTOR pathway","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005826423,0.0002285438,0.001782995,0.0001694647,0.00006681469,0.000003831807,0.00008995304,0.0001420698,0.00001881656],"category_scores_gemma":[0.0001982764,0.0001055359,0.0003695818,0.0002127384,0.0002231488,0.00007715773,0.000007901391,0.0001729315,3.035829e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003101181,"about_ca_system_score_gemma":0.0007558416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007489067,"about_ca_topic_score_gemma":0.004157661,"domain_scores_codex":[0.9966596,0.0005217116,0.001981119,0.0002147045,0.0003832422,0.0002396078],"domain_scores_gemma":[0.9956104,0.002079701,0.001754031,0.0002185412,0.0001312782,0.0002060468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1206384,0.1287613,0.4527325,0.000003231336,0.0008687993,0.0009526982,0.003518372,0.00002583807,0.00003161584,0.000001697113,0.0000484431,0.2924171],"study_design_scores_gemma":[0.2814705,0.3184821,0.3975361,0.00001819041,0.0003820771,0.00006042163,0.0003181046,0.00002116314,0.0001806863,0.000001595348,0.001490413,0.00003869589],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948673,0.001217488,0.000001557492,0.001320846,0.0003114218,0.002240134,0.00001667231,0.000003575389,0.00002106204],"genre_scores_gemma":[0.9787773,0.02030281,0.0001616279,0.0001205332,0.0004814104,0.0001295848,0.000005241463,0.00001387826,0.000007642559],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2923784,"threshold_uncertainty_score":0.4303629,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09951748353643922,"score_gpt":0.439709968423072,"score_spread":0.3401924848866328,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}